Bigfoot Biomedical Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 94

Employees

  • Latest Deal Type
  • M&A

Bigfoot Biomedical General Information

Description

Developer of a diabetes management system designed to reduce the cognitive, emotional, and financial burden of insulin-requiring diabetes. The company's system optimizes the dosing and delivery of insulin through an integrated medical device ecosystem powered by machine learning and enhanced by secured and user-friendly consumer technologies, enabling patients to live healthy lives with better diabetes disease management.

Contact Information

Formerly Known As
SmartLoop Labs
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 1820 McCarthy Boulevard
  • Milpitas, CA 95035
  • United States
+1 (408)
Primary Industry
Monitoring Equipment
Other Industries
Other Devices and Supplies
Parent Company
Corporate Office
  • 1820 McCarthy Boulevard
  • Milpitas, CA 95035
  • United States
+1 (408)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bigfoot Biomedical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Merger/Acquisition 22-Sep-2023 Completed Generating Revenue
7. Later Stage VC 01-Nov-2022 Completed Generating Revenue
6. Later Stage VC 17-Mar-2021 Completed Generating Revenue
5. Later Stage VC (Series C) 02-Jun-2020 Completed Generating Revenue
4. Accelerator/Incubator 01-Jun-2019 Completed Generating Revenue
3. Early Stage VC (Series B) 28-Mar-2018 Completed Generating Revenue
2. Early Stage VC (Series A) 19-Oct-2016 $36M $38M Completed Startup
1. Seed Round 01-Dec-2014 $2M $2M Completed Startup
To view Bigfoot Biomedical’s complete valuation and funding history, request access »

Bigfoot Biomedical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Junior 2
Series A 6,558,722 $0.000100 $0.44 $5.55 $5.55 1x $5.55 36.69%
Junior Pref 2,000,000 $0.000100 $1 $1 $1 11.48%
To view Bigfoot Biomedical’s complete cap table history, request access »

Bigfoot Biomedical Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a diabetes management system designed to reduce the cognitive, emotional, and financial burden of insulin-r
Monitoring Equipment
Milpitas, CA
94 As of 2024

San Diego, CA
 

Germantown, MD
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Bigfoot Biomedical Competitors (9)

One of Bigfoot Biomedical’s 9 competitors is GlySens, a Venture Capital-Backed company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
GlySens Venture Capital-Backed San Diego, CA
Senseonics Formerly VC-backed Germantown, MD
iHealth (Medical Supplies) Formerly VC-backed Sunnyvale, CA
LifeScan Private Equity-Backed Malvern, PA
DexCom Formerly VC-backed San Diego, CA
You’re viewing 5 of 9 competitors. Get the full list »

Bigfoot Biomedical Patents

Bigfoot Biomedical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20250050038-A1 Adaptable reuseable accessory, detecting reversible attachment of medication delivery device therein, and kit thereof Pending 08-Aug-2023
US-20240366885-A1 Medication delivery devices, systems and methods Pending 05-May-2023
US-20240339190-A1 Management process for insulin therapy using reinforcement learning and therapy escalation pathways Pending 07-Apr-2023
US-20240293618-A1 Determination of doses of insulin and related systems, methods, and devices Pending 10-Feb-2023
US-20240207532-A1 Cap for use with variety of injection pens and related devices and methods Pending 27-Dec-2022 A61M5/3202
To view Bigfoot Biomedical’s complete patent history, request access »

Bigfoot Biomedical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Bigfoot Biomedical Former Investors (22)

Investor Name Investor Type Holding Investor Since Participating Rounds
Abbott Ventures Corporate Venture Capital Minority
Agrocorp Ventures Venture Capital Minority
Angel (individual) Minority
Angel (individual) Minority
Cormorant Asset Management PE/Buyout Minority
You’re viewing 5 of 22 investors. Get the full list »

Bigfoot Biomedical Acquisitions (3)

Bigfoot Biomedical’s most recent deal was a Merger/Acquisition with Common Sensing. The deal was made on 14-Jun-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Common Sensing 14-Jun-2021 Merger/Acquisition Monitoring Equipment
Timesulin 08-Jun-2017 Merger/Acquisition Monitoring Equipment
Asante Solutions 28-May-2015 Merger/Acquisition Therapeutic Devices
To view Bigfoot Biomedical’s complete acquisitions history, request access »

Bigfoot Biomedical Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Timesulin London, United Kingdom 2010

Bigfoot Biomedical FAQs

  • When was Bigfoot Biomedical founded?

    Bigfoot Biomedical was founded in 2014.

  • Where is Bigfoot Biomedical headquartered?

    Bigfoot Biomedical is headquartered in Milpitas, CA.

  • What is the size of Bigfoot Biomedical?

    Bigfoot Biomedical has 94 total employees.

  • What industry is Bigfoot Biomedical in?

    Bigfoot Biomedical’s primary industry is Monitoring Equipment.

  • Is Bigfoot Biomedical a private or public company?

    Bigfoot Biomedical is a Private company.

  • What is Bigfoot Biomedical’s current revenue?

    The current revenue for Bigfoot Biomedical is .

  • How much funding has Bigfoot Biomedical raised over time?

    Bigfoot Biomedical has raised $212M.

  • Who are Bigfoot Biomedical’s investors?

    Abbott Ventures, Agrocorp Ventures, , , and Cormorant Asset Management are 5 of 22 investors who have invested in Bigfoot Biomedical.

  • Who are Bigfoot Biomedical’s competitors?

    GlySens, Senseonics, iHealth (Medical Supplies), LifeScan, and DexCom are some of the 9 competitors of Bigfoot Biomedical.

  • When was Bigfoot Biomedical acquired?

    Bigfoot Biomedical was acquired on 22-Sep-2023.

  • Who acquired Bigfoot Biomedical?

    Bigfoot Biomedical was acquired by Abbott.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »